Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 2,534,700 | 2,645,500 | 2,431,000 | 2,454,701 | 2,465,800 |
| Cost of Goods | 674,400 | 605,000 | 629,300 | 583,500 | 638,700 |
| Gross Profit | 1,860,300 | 2,040,500 | 1,801,700 | 1,871,200 | 1,827,100 |
| Operating Expenses | 1,269,300 | 1,247,800 | 1,422,400 | 1,430,300 | 1,362,000 |
| Operating Income | 591,400 | 792,700 | 379,600 | 441,401 | 465,800 |
| Other Income | -34,100 | -48,700 | -68,400 | -149,901 | -14,800 |
| Pre-tax Income | 557,300 | 744,000 | 311,200 | 291,500 | 451,000 |
| Income Tax | 90,800 | 109,200 | 70,700 | 24,800 | 62,500 |
| Net Income Continuous | 466,500 | 634,800 | 240,500 | 266,700 | 388,500 |
| Net Income | $466,500 | $634,800 | $240,500 | $266,700 | $388,500 |
| EPS Basic Total Ops | 3.18 | 4.33 | 1.65 | 1.82 | 2.67 |
| EPS Basic Continuous Ops | 3.18 | 4.33 | 1.65 | 1.83 | 2.67 |
| EPS Diluted Total Ops | 3.17 | 4.33 | 1.64 | 1.82 | 2.66 |
| EPS Diluted Continuous Ops | 3.17 | 4.33 | 1.64 | 1.83 | 2.66 |
| EPS Diluted Before Non-Recurring Items | 4.81 | 5.47 | 3.02 | 3.44 | 4.08 |
| EBITDA(a) | $855,100 | $1,043,000 | $614,200 | $710,301 | $719,700 |